Deep oceans contain microbes with yet-to-be-discovered properties that could drive future innovations in biotechnology.
Ancient evidence suggests a new twist in how we all got here.
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...